These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 520157)

  • 21. [Current treatment of pyoseptic complications of acute hepatorenal insufficiency].
    Shimanko II; Galstukhov AV; Galkina GS
    Vestn Akad Med Nauk SSSR; 1988; (9):39-44. PubMed ID: 3201818
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development and correction of water-electrolyte and acid-base-equilibrium disorders in gastrointestinal diseases (including liver) (proceedings)].
    Base W; Dragosics B; Wewalka F
    Klin Anasthesiol Intensivther; 1977; (15):137-46. PubMed ID: 926700
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatic failure and disorders of coagulation (author's transl)].
    Ohler WG
    Leber Magen Darm; 1977 Aug; 7(4):270-6. PubMed ID: 895329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute hepatic insufficiency and the artificial liver].
    Sandu L
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1981; 30(2):145-58. PubMed ID: 6454910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 26. [A clinico-experimental study of lymphogenous detoxification in acute renal and kidney insufficiency].
    Novikova RI; Shano VP; Abashina TE; Logvinenko LV; Shramenko EK; Mareeva TE
    Anesteziol Reanimatol; 1989; (4):35-8. PubMed ID: 2817496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of fibrin stabilization in liver and kidney disease: a comparison of two different methods.
    Walls WD; Losowsky MS
    Clin Sci; 1969 Dec; 37(3):837-46. PubMed ID: 5363577
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment if acute hepatic failure].
    Pár A
    Orv Hetil; 2003 Aug; 144(35):1735-6. PubMed ID: 14533356
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kideny and hepato-biliary diseases].
    Thiele KG
    Dtsch Med Wochenschr; 1976 Jul; 101(30):1134-40. PubMed ID: 942568
    [No Abstract]   [Full Text] [Related]  

  • 30. The gut hormone profile of fulminant hepatic failure.
    Sullivan SN; Chase RA; Christofides ND; Bloom SR; Williams R
    Am J Gastroenterol; 1981 Oct; 76(4):338-41. PubMed ID: 7325145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Major complications of acute and chronic liver disease.
    Munoz SJ; Maddrey WC
    Gastroenterol Clin North Am; 1988 Jun; 17(2):265-87. PubMed ID: 3049345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fulminant hepatic failure and hepatic encephalopathy.
    Rogers EL; Rogers MC
    Pediatr Clin North Am; 1980 Aug; 27(3):701-13. PubMed ID: 7413297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation.
    Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V
    J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotransmitters and hepatic failure.
    Fischer JE
    Conn Med; 1972 Oct; 36(10):579-81. PubMed ID: 4404444
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutic constraints in hepatic insufficiency.
    Summerskill WH
    Adv Intern Med; 1972; 18():411-24. PubMed ID: 4576086
    [No Abstract]   [Full Text] [Related]  

  • 36. [Principles and methods for the complex treatment of acute hepatic and hepatorenal failure].
    Komarov BD; Shimanko II; Musselius SG; Rimalis BTs
    Vestn Akad Med Nauk SSSR; 1983; (10):19-30. PubMed ID: 6649853
    [No Abstract]   [Full Text] [Related]  

  • 37. [Glucocorticotherapy in hepatic diseases].
    Boroń P; Borzuchowska A; Modzelewski T
    Przegl Lek; 1970; 26(10):753-5. PubMed ID: 5484242
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of acute hepatic encephalopathy.
    Chamuleau RA
    Neth J Med; 1979; 22(6):203-9. PubMed ID: 118390
    [No Abstract]   [Full Text] [Related]  

  • 39. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ; Losowsky MS
    Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term therapy of liver diseases].
    Markoff N
    Wien Med Wochenschr; 1972 Feb; 122(7):95-9. PubMed ID: 4621921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.